Seattle genetics reports q3 loss per share of $0.55

Seattle genetics reports third quarter 2019 financial results.q3 loss per share $0.55.q3 earnings per share estimate $-0.36 -- refinitiv ibes data.qtrly net sales in u.s. and canada of $167.6 million, up 32%.anticipate global sales of adcetris to exceed $1.0 billion in 2019.total revenues in q3 increased to $213.3 million $169.4 million.sees adcetris net product sales of $625 million to $640 million in 2019.sees royalty revenues of $90 million to $95 million in 2019.
SGEN Ratings Summary
SGEN Quant Ranking